The growing use of GLP-1 weight-loss medications is beginning to reshape how consumers eat, drink and socialise, presenting both challenges and opportunities for hospitality businesses. New research suggests that operators may need to adapt menus and marketing as eating habits continue to evolve.

Consumers using weight-loss medications such as Ozempic, Wegovy and Mounjaro are typically eating smaller portions, snacking less frequently and drinking less alcohol. While many continue to enjoy eating out, they are placing greater emphasis on food quality, healthier options and overall dining experiences rather than quantity.

The research suggests there is an opportunity for hospitality businesses to respond by offering more flexible portion sizes, lighter dishes, premium ingredients and an expanded range of low- and no-alcohol drinks. Creating memorable experiences and delivering value beyond the size of a meal is also expected to become increasingly important as consumer behaviours continue to shift.

While the trend is still emerging, it highlights the importance of understanding changing customer preferences and adapting menus to meet evolving demand. Businesses that respond proactively are likely to be best placed to attract and retain customers as the market continues to evolve.

If you'd like support building and engineering your menus to ensure you're meeting the changing consumer demands, get in touch with our team today. Our procurement managers, along with our team of culinary experts can provide advice and guidance.